LEADER 03359nam  22005534a 450 
001 9910830218403321
005 20230617005514.0
010   $a1-280-19688-2
010   $a9786610196883
010   $a0-470-98411-2
010   $a0-470-98844-4
010   $a1-4051-4101-8
035   $a(CKB)1000000000341992
035   $a(EBL)228604
035   $a(OCoLC)63052733
035   $a(SSID)ssj0000261514
035   $a(PQKBManifestationID)11217465
035   $a(PQKBTitleCode)TC0000261514
035   $a(PQKBWorkID)10268729
035   $a(PQKB)11637461
035   $a(MiAaPQ)EBC228604
035   $a(EXLCZ)991000000000341992
100   $a20040306d2004      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aTransient ischemic attacks$b[electronic resource] /$fedited by Seemant Chaturvedi and Steven R. Levine
210   $aMalden, Mass. $cBlackwell Futura$dc2004
215   $a1 online resource (476 p.)
300   $aDescription based upon print version of record.
311   $a1-4051-2059-2 
320   $aIncludes bibliographical references and index.
327   $aTransient Ischemic Attacks; Contents; List of Contributors; Foreword; Preface; Part I: Clinical Background; Chapter 1: The Epidemiology of Transient Ischemic Attacks; Chapter 2: Pathophysiology of Brain Ischemia; Chapter 3: Clinical Syndromes-Brain; Chapter 4: Clinical Syndromes-Ocular: Transient Visual Loss; Part II: Diagnostic Studies; Chapter 5: Head CT and MRI Findings in Patients with Transient Ischemic Attacks; Chapter 6: Single-Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET); Chapter 7: Cerebrovascular Ultrasound; Chapter 8: Cardiac Diagnostic Studies
327   $aChapter 9: Coagulation StudiesPart III: Medical Therapy; Chapter 10: Antiplatelet Therapy; Chapter 11: Role of Oral Anticoagulants; Chapter 12: Heparin and Related Compounds; Chapter 13: Diabetes Mellitus Treatment; Chapter 14: Hypertension Treatment; Chapter 15: Other Medical Therapies; Chapter 16: Thrombolysis for Acute Transient Ischemic Attack and Mild Stroke; Part IV: Surgical and Interventional Treatments and Cost-Effectiveness; Chapter 17: Surgery for Stroke Prevention; Chapter 18: Angioplasty and Stenting; Chapter 19: Cost Effectiveness Issues; Chapter 20: Clinical Vignettes; Index
330   $aThis book was born from the synthesis of the rapidly proliferating field of cerebrovascular disease research, excitement about effective new imaging and therapeutic strategies, and the need to timely educate clinicians about the changing playing field for a common, serious and expensive syndrome - transient ischemic attacks (TIA). TIAs can now stand on their own as an important, and, at times, unique aspect of symptomatic cerebrovascular disease, distinct enough to warrant a textbook in its own right. With new information on a worrisome and serious natural history, growing knowledge of risk fa
606   $aCerebral ischemia
615  0$aCerebral ischemia.
676   $a616.81
701   $aChaturvedi$b Seemant$0881290
701   $aLevine$b Steven R$0881291
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910830218403321
996   $aTransient ischemic attacks$91968219
997   $aUNINA